LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.056234
 51.33 27.76 778 5117 0.1520 0.5572
MN20160318_Q01
K13
MCF 10A-H2B-mCherry Neratinib
0.056234
 51.33 27.76 3179 5117 0.6213 0.8774
MN20160318_Q01
K13
MCF 10A-H2B-mCherry Neratinib
0.056234
 53.04 27.76 78 5365 0.0145 0.1457
MN20160318_Q01
I13
MCF 10A-H2B-mCherry Neratinib
0.056234
 53.04 27.76 3636 5365 0.6776 0.9001
MN20160318_Q01
I13
MCF 10A-H2B-mCherry Neratinib
0.056234
 53.04 27.76 882 5365 0.1644 0.5768
MN20160318_Q01
K13
MCF 10A-H2B-mCherry Neratinib
0.056234
 53.04 27.76 3388 5365 0.6314 0.8825
MN20160318_Q01
K13
MCF 10A-H2B-mCherry Neratinib
0.056234
 54.74 27.76 88 5606 0.0157 0.1626
MN20160318_Q01
I13
MCF 10A-H2B-mCherry Neratinib
0.056234
 54.74 27.76 3819 5606 0.6812 0.9022
MN20160318_Q01
I13
MCF 10A-H2B-mCherry Neratinib
0.056234
 54.74 27.76 1075 5606 0.1917 0.6120
MN20160318_Q01
K13
MCF 10A-H2B-mCherry Neratinib
0.056234
 54.74 27.76 3701 5606 0.6601 0.8944
MN20160318_Q01
K13
MCF 10A-H2B-mCherry Neratinib
0.056234
 56.45 27.76 107 5745 0.0186 0.1917
MN20160318_Q01
I13
MCF 10A-H2B-mCherry Neratinib
0.056234
 56.45 27.76 4081 5745 0.7103 0.9130
MN20160318_Q01
I13
MCF 10A-H2B-mCherry Neratinib
0.056234
 56.45 27.76 1193 5745 0.2076 0.6304
MN20160318_Q01
K13
MCF 10A-H2B-mCherry Neratinib
0.056234
 56.45 27.76 3902 5745 0.6792 0.9019
MN20160318_Q01
K13
MCF 10A-H2B-mCherry Neratinib
0.056234
 58.15 27.76 116 5906 0.0196 0.2031
MN20160318_Q01
I13
MCF 10A-H2B-mCherry Neratinib
0.056234
 58.15 27.76 4351 5906 0.7366 0.9225
MN20160318_Q01
I13
MCF 10A-H2B-mCherry Neratinib
0.056234
 58.15 27.76 1279 5906 0.2165 0.6410
MN20160318_Q01
K13
MCF 10A-H2B-mCherry Neratinib
0.056234
 58.15 27.76 4171 5906 0.7062 0.9120
MN20160318_Q01
K13
MCF 10A-H2B-mCherry Neratinib
0.056234
 59.85 27.76 125 6062 0.0206 0.2137
MN20160318_Q01
I13
MCF 10A-H2B-mCherry Neratinib
0.056234
 59.85 27.76 4638 6062 0.7650 0.9322
MN20160318_Q01
I13
MCF 10A-H2B-mCherry Neratinib
0.056234
 59.85 27.76 1432 6062 0.2362 0.6610
MN20160318_Q01
K13
MCF 10A-H2B-mCherry Neratinib
0.056234
 59.85 27.76 4394 6062 0.7248 0.9188
MN20160318_Q01
K13
MCF 10A-H2B-mCherry Neratinib
0.056234
 61.56 27.76 147 6217 0.0236 0.2380
MN20160318_Q01
I13
MCF 10A-H2B-mCherry Neratinib
0.056234
 61.56 27.76 4876 6217 0.7843 0.9387
MN20160318_Q01
I13
MCF 10A-H2B-mCherry Neratinib
0.056234
 61.56 27.76 1478 6217 0.2377 0.6639
MN20160318_Q01
K13